Replication Data for: Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, and JN.1.4, using samples from two health demographic surveillance systems in Kenya (doi:10.7910/DVN/6DSHMB)

View:

Part 1: Document Description
Part 2: Study Description
Part 5: Other Study-Related Materials
Entire Codebook

Document Description

Citation

Title:

Replication Data for: Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, and JN.1.4, using samples from two health demographic surveillance systems in Kenya

Identification Number:

doi:10.7910/DVN/6DSHMB

Distributor:

Harvard Dataverse

Date of Distribution:

2024-06-24

Version:

1

Bibliographic Citation:

Lugano, Doreen; Kutima, Bernadette; Kimani, Makobu; Sigilai, Antipa; Gitonga, John N.; Karani, Angela; Akech, Donald; Karia,Boniface; Wairimu, Angela; Lambisia, Arnold; Omuoyo, Donwilliams; Lucinde, Ruth; Ziraba, Abdhalah K.; Newman, Joseph; Bailey, Dalan; Githinji, George; Agoti, Charles N.; Sande, Charles; Kagucia, Wangeci; Ochola-Oyier, Lynette I.; Bejon, Philip; Scott, J. Anthony G.; Agweyu, Ambrose; Warimwe, George M.; Nyagwange, James, 2024, "Replication Data for: Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, and JN.1.4, using samples from two health demographic surveillance systems in Kenya", https://doi.org/10.7910/DVN/6DSHMB, Harvard Dataverse, V1

Study Description

Citation

Title:

Replication Data for: Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, and JN.1.4, using samples from two health demographic surveillance systems in Kenya

Identification Number:

doi:10.7910/DVN/6DSHMB

Authoring Entity:

Lugano, Doreen (KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya)

Kutima, Bernadette (KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya)

Kimani, Makobu (KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya)

Sigilai, Antipa (KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya)

Gitonga, John N. (KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya)

Karani, Angela (KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya)

Akech, Donald (KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya)

Karia,Boniface (KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya)

Wairimu, Angela (KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya)

Lambisia, Arnold (KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya)

Omuoyo, Donwilliams (KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya)

Lucinde, Ruth (KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya)

Ziraba, Abdhalah K. (African Population and Health Research Center)

Newman, Joseph (The Pirbright Institute, Ash Road, Woking, GU24 0NF, Surrey, United Kingdom)

Bailey, Dalan (The Pirbright Institute, Ash Road, Woking, GU24 0NF, Surrey, United Kingdom)

Githinji, George (KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya)

Agoti, Charles N. (KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya)

Sande, Charles (KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya)

Kagucia, Wangeci (KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya)

Ochola-Oyier, Lynette I. (KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya)

Bejon, Philip (KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya)

Scott, J. Anthony G. (KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya)

Agweyu, Ambrose (KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya)

Warimwe, George M. (KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya)

Nyagwange, James (KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya)

Distributor:

Harvard Dataverse

Access Authority:

Nyagwange, James

Access Authority:

The Data Governance Committee

Depositor:

Lugano, Doreen

Date of Deposit:

2024-06-24

Holdings Information:

https://doi.org/10.7910/DVN/6DSHMB

Study Scope

Keywords:

Medicine, Health and Life Sciences, SARS-CoV-2 variants, vaccination, neutralization, population immunity

Abstract:

<p>This is a replication dataset for the manuscript titled:<strong><i>Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, and JN.1.4, using samples from two health demographic surveillance systems in Kenya</I></strong>.</p> <p>SARS-CoV-2 virus continues to mutate leading to emerging variants that escape immunity previously raised by vaccination and/or infection by earlier variants. We used genomic data to identify the most prevalent Kenyan and global variants between May 2023 and March 2024 and performed pseudoviruses neutralization assays on samples collected from two health demographic surveillance systems in Kenya (n=54), for vaccine induced immunity against circulating variants EG.5.1, FY.4 19, BA.2.86, JN.1, and JN.1.4. As a comparator, we used natural wildtype infection samples (n=20) collected in 2020 at the onset of the pandemic and confirmed to be PCR positive for SARS-CoV-2. We also assessed the effects of different doses of vaccine, age, sex, and type of vaccine on antibody-neutralizing titers.</p>

Kind of Data:

Open Access

Notes:

<strong>Data Access </strong>: Data will be open access under the terms of the Creative Commons CC By 4.0 License.

Methodology and Processing

Sources Statement

Data Access

Availability Status:

Data will be open access under the terms of the Creative Commons CC By 4.0 License.

Other Study Description Materials

Related Publications

Citation

Title:

Nyagwange, J. et al. Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro. International Journal of Infectious Diseases 127, (2023). Lambisia, A. W. et al. Detection of a SARS-CoV-2 Beta-like variant in coastal Kenya after more than a year of disappearance. Wellcome Open Res 8, (2023).

Bibliographic Citation:

Nyagwange, J. et al. Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro. International Journal of Infectious Diseases 127, (2023). Lambisia, A. W. et al. Detection of a SARS-CoV-2 Beta-like variant in coastal Kenya after more than a year of disappearance. Wellcome Open Res 8, (2023).

Citation

Title:

Mwanga, M. J. et al. New SARS-CoV-2 Omicron Variant with Spike Protein Mutation Y451H, Kilifi, Kenya, March-May 2023. Emerg Infect Dis 29, (2023).

Bibliographic Citation:

Mwanga, M. J. et al. New SARS-CoV-2 Omicron Variant with Spike Protein Mutation Y451H, Kilifi, Kenya, March-May 2023. Emerg Infect Dis 29, (2023).

Citation

Title:

Githinji, G. et al. The genomic epidemiology of SARS-CoV-2 variants of concern in Kenya. medRxiv (2022).

Bibliographic Citation:

Githinji, G. et al. The genomic epidemiology of SARS-CoV-2 variants of concern in Kenya. medRxiv (2022).

Citation

Title:

Kagucia, E. W. et al. SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February–December 2022. Influenza Other Respir Viruses 17, (2023).

Bibliographic Citation:

Kagucia, E. W. et al. SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February–December 2022. Influenza Other Respir Viruses 17, (2023).

Citation

Title:

Uyoga, S. et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors. Science (1979) 371, (2021)

Bibliographic Citation:

Uyoga, S. et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors. Science (1979) 371, (2021)

Citation

Title:

Kagucia, E. W. et al. SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February–December 2022. Influenza Other Respir Viruses 17, (2023)

Bibliographic Citation:

Kagucia, E. W. et al. SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February–December 2022. Influenza Other Respir Viruses 17, (2023)

Other Study-Related Materials

Label:

Code.zip

Notes:

application/zip

Other Study-Related Materials

Label:

Data.zip

Notes:

application/zip

Other Study-Related Materials

Label:

DLugano_DATASET_Readme_14062024.txt

Notes:

text/plain